WAS and Wiskott-Aldrich syndrome: Microinjection of Cas9 mRNA and a pair of sgRNAs targeting exons 2 and 7 of WAS into rabbit embryos was performed to generate a model exhibiting symptoms similar to those of WAS patients for preclinical studies (232).